ABBOTINDIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Abbott India's board, meeting on November 6, 2025, approved unaudited financial results for Q2 FY26 and H1 FY26 (ended September 30, 2025). Revenue from operations for Q2 stood at Rs 1,757.15 crore, up 7.6% from Rs 1,632.67 crore in Q2 FY25. For H1 FY26, revenue rose to Rs 3,495.50 crore vs Rs 3,190.28 crore last year, a 9.6% increase. Profit after tax for Q2 grew to Rs 415.27 crore (from Rs 358.61 crore), while H1 PAT reached Rs 781.13 crore vs Rs 686.62 crore. EPS for Q2 stood at Rs 195.42. The statutory auditor Walker Chandiok & Co LLP issued a clean limited review report with no qualifications. Operating cash flow for H1 FY26 was healthy at Rs 521.94 crore.
Steady double-digit profit growth and a clean audit report are positive for shareholders, signaling consistent operational performance. However, revenue growth in single digits (under 10%) suggests modest top-line momentum rather than acceleration.